Innovation Projects

ClassIDM – Integrated Care for Chronic Diseases

Project leader: BD
German / Swiss partners: Profil Institut für Stoffwechselforschung GmbH

ClassIDM aims at establishing a test case demonstrating the clinical impact of a prototype Interconnected Diabetes Management (IDM) assistance system for improving metabolic control and life quality in patients with type 2 diabetes (T2D patients). ClassIDM will integrate functionalities enabling T2D patients to better manage their disease, with a strong behavioural approach, supported by a data collection and processing ecosystem, a data visualization platform and a Clinician portal.

ClassIDM

Individual Prostate Cancer Risk Score (STHLM3)

Project leader: Karolinska Institutet, Thermo Fisher
German / Swiss partners: Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg, Janssen-Cilag

The aim of this project is to introduce, assess and refine a new application for individualised prostate cancer risk, the STHLM3 Risk Score. The STHLM3 Risk Score finds 20% more aggressive cancers and reduces the number of unnecessary biopsies with more than 50% compared to current clinical practice. The STHLM3 Risk Score was developed in a joint clinical research program between Thermo Fisher Scientific, a Swedish HCP and KI, combining genetic and protein biomarkers with clinical data in a multivariate algorithm.

STHML3

CLOSE

Project leader: Profil Institut für Stoffwechselforschung GmbH
German / Swiss partners: Roche Diagnostics GmbH, Institute for Applied Quality Improvement and Research in Health Care GmbH, European Research and Project Office GmbH

CLOSE develops and deploys an integrated package centred on closed loop metabolic control for severely ill patients with Type 2 Diabetes. CLOSE will boost homecare service provision, improve quality of life of patients and their families and increase the sustainability of health care systems.

CLOSE

P3-Stroke

Project leader: Siemens AG
German / Swiss partners: Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen

P3-Stroke will develop, implement and validate an integrated hybrid Angio-MRI system. This will improve the predictive prevention and personalised interventional stroke therapy, resulting in lower healthcare and socioeconomic costs and a unique selling proposition with new business opportunities.

P3-Stroke

PersoCo

Project leader: Philips Electronics Nederland B.V.
German / Swiss partners: Technische Universität München

PersoCo will develop a digital cognitive assessment and intervention service for people experiencing cognitive decline. Users get insight into their cognitive functioning and are offered solutions for their daily life problems. Prolonged usage is stimulated by innovative personalised engagement techniques.

PersoCo

Vitality

Project leader: Philips
German / Swiss partners: Deutsches Zentrum für Diabetesforschung (DZD)

Vitality integrates a self-management service, promoting healthy living to prevent the risk of diabetes and prevent worsening of diabetes, in the offerings and vitality platforms of insurance companies and service providers and will be endorsed by medical and non-medical professionals. The service includes lifestyle monitoring devices and a personalized coaching service focusing on daily life. The consortium consists of leading partners in the field.

Vitality

ComRAD – World’s first respiratory assist device

Project leader: RWTH Aachen
German / Swiss partners: Uniklinik Aachen

ComRAD is the world’s first respiratory assist device specifically designed for long term treatment of patients with life threatening lung diseases. The device uses an innovative approach for heart-lung support by mimicking the elasticity of the native lungs. That makes the device more efficient with significantly lower associated risks while also allowing affected patients for the first time to be mobilized again.

Comrad

LUCINDA

Project leader: Oxford University Hospitals NHS Trust
German / Swiss partners: Universitätsklinikum Heidelberg

Lung cancer is the most lethal cancer. Early detection by Computed Tomography (CT) significantly improves survival. Lung Virtual Biopsy enables earlier, more confident and cost-efficient lung cancer diagnosis, using the existing CT scanner available in almost every modern hospital, Machine Learning and vast database of CT scans.

Lucinda

Therapy Lens

Project leader: Technische Universität München (TUM)
German / Swiss partners: RWTH Aachen

The Therapy Lens app will utilize the latest augmented reality technology in order to provide virtual support for patients with neurological diseases at home. Using the Microsoft HoloLens users will receive support from the app through holograms presented in their field of view. These holograms provide a foundation for the four main features of the app: a “virtual carer”, virtual support in complex tasks, rehabilitation games and an artificial intelligence companion.

Therapy-Lens-1

Active Hands

Project leader: Technische Universität München

The Active Hands project will develop an innovative home-based guidance system that will support individuals who have suffered functional loss in daily tasks such as tea making. The platform will track the movements made by a user during the task and provide tailored information about the correct next task action if an error is performed.

The-Active-Hands-Project

AVC (finished in 2016)

Project leader: AbbVie Deutschland GmbH & Co. KG
German / Swiss partners: Ruprecht-Karls-Universität Heidelberg

AbbVie Cares improves work-related health, work-ability and productivity for people at AbbVie and beyond. The KAVA accelerates technology readiness and scalability with four components: a toolbox for monitoring health-related work-site interventions and three comprehensive educational suites.

DeTecT2D

Project leader: Deutsches Zentrum für Diabetesforschung e.V.
German / Swiss partners: Technische Universität München, Universitätsklinikum Tübingen, Ludwig-Maximilians- Universität, Helmholtz Zentrum München

The early detection of Type 2 diabetes (T2D) is essential to apply intervention strategies, enable healthy ageing and lessen the burden on healthcare systems. DeTecT2D aims to develop and commercialise a diagnostic assay to replace OGTT, and to train young researchers in translational implementation.

Detect2D

HandTech

Project leader: ETH Zürich
German / Swiss partners: Hocoma

Cooperative hand movements are based on a neural coupling mechanism. After stroke the unaffected hemisphere becomes involved in movement performance of the paretic hand. This effect can be enhanced by a training of cooperative hand movements required during daily life activities with the consequence of an improved quality of life. A novel training device will allow such a training of cooperative hand movements.

I4PCM

Project leader: Institut de Cancérologie Gustave Roussy
German / Swiss partners: Deutsches Krebsforschungszentrum, AbbVie Deutschland GmbH & Co. KG Roche Diagnostics GmbH, SAP

I4PCM involves six EU centres to create a common data platform addressing current challenges in cancer medicine, leading the way for a virtual European Cancer Institute. The project will explore care and clinical research as well as identify patient responses to immunotherapy through biology, genomics, and imaging.

I4PCM

MACH

Project leader: Rheinisch-Westfaelische Technische Hochschule Aachen
German / Swiss partners: BerlinHeart GmbH

Children in end-stage heart failure awaiting transplantation are hit harder by the shortage in donor organs than adults: Due to the lack of miniaturised heart assist devices, they are constantly “detained” in intensive care wards. The device developed will help children regain a greater degree of independence.

MACH